Link Pharma Chem Ltd reported a net loss of Rs 0.22 crore for the quarter ended September 30, 2026, marking a sharp decline from the Rs 0.32 crore profit recorded in the previous quarter. Revenue from operations dropped by 39% sequentially to Rs 5.33 crore. The company maintains an unmodified auditor report, though shrinking cash reserves and operational cash outflows remain key areas for shareholder attention.
Link Pharma Chem Reports Q2 Net Loss of Rs 0.22 Crore
Revenue from operations fell 39% sequentially to Rs 5.33 crore, with a net loss of Rs 0.22 crore reported for the quarter.
Reader Takeaway: Revenue contraction and operating cash outflows pressure the bottom line, despite an unmodified auditor's report.
What just happened
Link Pharma Chem Ltd declared its financial results for the quarter ended September 30, 2026. The company reported a net loss of Rs 0.22 crore, a significant reversal from the Rs 0.32 crore profit in the June 2026 quarter. Revenue from operations decreased to Rs 5.33 crore compared to Rs 8.77 crore in the previous quarter.
Why this matters
The sequential decline in revenue and the shift from profit to loss indicate operational headwinds. Furthermore, the company recorded a net cash outflow from operating activities of Rs 1.88 crore for the half-year, compared to a net inflow of Rs 1.19 crore in the same period last year. Cash and cash equivalents have also tightened to Rs 0.03 crore.
What changes now
Shareholders should monitor the company's efforts to revive topline growth and stabilize operating margins. The statutory auditor, CNK & Associates LLP, issued an unmodified conclusion, confirming that the financial statements comply with accounting standards.
What to track next
Investors should watch for recovery in operational cash flow and any strategic measures the company adopts to restore profitability in the upcoming quarters.